SBFM Sunshine Biopharma Inc.

$2.12 +1.44%

Healthcare · Pharmaceutical Preparations

Sunshine Biopharma Inc. (SBFM) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $11 million. Shares last traded at $2.12, 55.8% below their 52-week high. Over the past year the stock is up 59.4%. Net profit margin is -16.5%, below the peer median of -0.1%. Revenue grew 4.1% year over year.

Market Cap

$11M

Shares Out

5.0M

EPS (TTM)

$-15.85

P/E Ratio

—

P/S Ratio

0.29

P/B Ratio

0.49

Dividend / Share

—

Dividend Yield

—

52-Week High

$4.80

52-Week Low

$0.25

Volume

682

Avg Vol (3m)

199,797.73

Performance

-10.55%

+404.76%

+78.15%

+44.22%

YTD

+68.25%

+59.40%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

59.95

SMA (50)

$1.25

SMA (200)

$1.37

Price vs SMA50

+70.27%

Price vs SMA200

+55.28%

ATR (14)

$0.30

Financials

Revenue

$36M

Net Income

$-6M

Gross Margin

33.8%

Operating Margin

-17.2%

Net Margin

-16.5%

Return on Equity

-27.8%

Return on Assets

-21.4%

Current Ratio

4.22

Debt / Equity

0.10

Revenue Growth (YoY)

+4.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q3 2025	$-0.98	2025-11-13
Q2 2025	$-0.82	2025-08-12
Q1 2025	$-0.44	2025-05-15
FY 2024	$-7.32	2025-04-01
Q3 2025	$-13.61	2025-11-13
Q2 2025	$-43.48	2025-08-12

Full earnings history →

Pharmaceutical Preparations peers

SBFM vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

0.29 / 3.54 med

-92% discount

Net margin vs peers

-16.5% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.